Neuroendocrine Tumors (NETs) — Lutetium-177-DOTATATE (Lu-177): treatment in Frankfurt am Main - Germany
Treatment prices are regulated by national law of the corresponding countries, but can also include additional hospital coefficients. In order to receive the individual cost calculation, please send us the request and medical records.
Department of Nuclear Medicine
The Department of Nuclear Medicine offers the full range of modern diagnostics and therapy using various radioisotopes. The department is equipped with the advanced systems for carrying out such high-precision and informative examinations as SPECT, PET, etc. The department carries out more than 8,000 outpatient examinations annually. The key focus in the field of diagnostics is on the detection of neurological, cardiac and oncological diseases. The department's therapeutic options include the treatment of benign and malignant diseases of the thyroid gland, pain therapy in bone metastases, treatment of malignant tumors in children (for example, neuroblastomas). The spectrum is also complemented by such innovative techniques as radiosynoviorthesis, selective internal radiation therapy and radioimmunotherapy.
Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms that arise in hormone-producing cells throughout the body: in the gastrointestinal tract, lungs, ovaries and kidneys. However, most often patients with neuroendocrine tumors suffer from neoplasms in the digestive tract, less commonly – lung neoplasms. Hospitals in Frankfurt-am-Main offer the innovative therapeutic option: treatment with Lutetium DOTATATE for gastrointestinal and lung NETs. Contact the international medical tourism provider Booking Health to find the most suitable healthcare facility and doctor exactly for your case, as well as check the cost of treatment in Frankfurt-am-Main.
Content
- How Lutetium-177-DOTATATE treatment for NETs work
- The procedure of Lutetium-177-DOTATATE therapy for NETs
- Lutetium cancer treatment in Frankfurt
How Lutetium-177-DOTATATE treatment for NETs work
Lutetium-177-DOTATATE used for NETs therapy is the combination of 3 components:
- Beta-emitting radioisotope Lutetium-177
- Chelating agent tetra-azacyclododecanetetra-acetic acid (DOTA)
- Tyrosine-containing somatostatin analog Tyr3-octreotate (TATE)
This is the optimal combination for the effective treatment of patients with neuroendocrine tumors. While DOTA and TATE components ensure targeted search of malignant cells and reliable bounding to them, Lu-177 is responsible for the tumor destruction. Actually, the therapy has the potential to elicit tumor cytoreduction and prolong disease control. This is rare among the other available therapeutic options. Thus, the rather high price of the procedure is justified by its efficacy; it can even reduce the overall treatment cost due to the usage of fewer other treatments.
The procedure of Lutetium-177-DOTATATE therapy for NETs
Lutetium-177-DOTATATE therapy is a type of inpatient NETs treatment, as the procedure includes administration of radioactive substances. After the physical examination and somatostatin receptor imaging with Ga-68 DOTATATE PET/CT, a doctor calculates the individual dosage of Lu-177-DOTATATE, and the procedure starts.
Lu-177-DOTATATE is administered via intravenous injection, through a catheter. Saline solutions and amino acid solutions will also be injected in order to protect your kidneys. Normally, the procedure takes no longer than 20 minutes, after which you stay under the medical supervision in the radiation-shielded for 48 hours.
After the follow-up whole-body scintigraphy or CT scan in 24 hours and 48 hours after the injection, you will receive further recommendations and will be discharged from the hospital.
Lutetium cancer treatment in Frankfurt
Hospitals in Frankfurt-am-Main have long been using the Lutetium-177 molecule for the treatment. These include both Lutetium-177 prostate cancer treatment in Frankfurt (combination of Lu-177 and PSMA) and administration of Lutetium-177-DOTATATE for NETs.
Not only German citizens, but also foreigners, can undergo Lutetium-177 treatment in Frankfurt for any malignant disease. Leave your request with contact information and basic medical data on the Booking Health website. Booking Health is the certified medical tourism provider (ISO 9001: 2015 certificate) that is authorized by hospitals in Frankfurt-am-Main to arrange treatment of patients from abroad.
Booking Health medical specialists will study your available medical reports, give you the best recommendations on the hospital and doctor, and elaborate the preliminary medical program with mentioning the expected prices. Company’s travel managers will take care of visa issuing, flights and transfer, accommodation, interpreter and all other organizational issues. In addition, prices for Booking Health patients will be the same as for German citizens, as additional taxes and fees will be excluded from the estimated treatment cost.
Authors:
The article was edited by medical experts, board-certified doctors Dr. Nadezhda Ivanisova and Dr. Vadim Zhiliuk. For the treatment of the conditions referred to in the article, you must consult a doctor; the information in the article is not intended for self-medication!
Sources: